Alzeca Biosciences develops novel advanced imaging agents for the early diagnosis of neurodegenerative diseases, including Alzheimer’s Disease. Alzheimer’s affects approximately 5.5M Americans at a cost of over $226 billion in care, and affects over 27 million patients worldwide. Its incidence is projected to quadruple by 2050 with costs exceeding $1 trillion in the US alone, […]
Investors 1
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
17.08.2017 | Series A | $11M | - | dolbyventu... |
Mentions in press and media 4